PPIases isomerases

A cytosolic binding protein for CsA was first isolated in 1984 and named cyclophilin, later cyclophilin A (CyPA), in reference to its high affinity for CsA (18). CyPA is a basic, abundant protein with a mass of 18 kDa, and it is found in a variety of tissues. The first clue to its function came in 1989 when two independent groups isolated the enzyme that catalyzes pepti-dyl proline isomerization/peptidylprolyl cis-trans isomerase (EC 5.2.1.8 PPIase), in protein chains and (re)discovered CyPA (19, 20). CyPA is a potent PPIase, and its enzymatic activity is strongly inhibited by CsA. 

Fluorine in biological mimics Peptidyl prolyl isomerases (PPIases)... 

Peptidyl prolyl cis-trans isomerases (PPIases) are able to catalyze the folding or unfolding reaction. 

To form catalytically productive enzyme/substrate complexes, many peptide bond cis-trans isomerases essentially require the location of the reactive bond of the substrate in the context of secondary binding sites or a specific spatial organization of the polypeptide chain thus creating features of stereo- and regiospecifi-city [19,20]. As in the case of many endoproteases, PPIases can utilize an extended array of catalytic subsites to enhance catalytic efficiency and substrate specificity. These properties precondition peptide bond cis-trans isomerases toward a complex reaction pattern. Consequently, biochemical investigations have led to the elucidation of three distinct molecular mechanisms that might be operative either in isolation or collectively in the cellular action of both prototypical and multidomain peptide bond cis-trans isomerases ... 

There is evidence that the trigger factor and the hsp70 chaperone DnaK, a PPIase and a secondary amide peptide bond cis-trans isomerase (APIase) respectively, contribute to the formation of native proteins by apparently overlapping functions with the trigger factor as the primary interaction partner of the emerging polypeptide chain [122-124]. Consequently, synthetic lethality was observed... 

Despite the amount of data and the simplicity of the chemical reaction catalyzed, the molecular basis of the catalytic mechanism of PPIases and APIases is still only poorly understood [155]. The considerable degree of amino acid sequence dissimilarity between the subgroups of peptide bond cis-trans isomerases also raises the challenging question of the mechanistic relatedness among the enzymes. At present there is a lack of detailed mechanistic investigations on APIases and multidomain PPIases. Thus, prototypic PPIases of all three families serve as the bases for unraveling catalytic pathways. One or more potential transition-state structures for enzyme-catalyzed prolyl isomerizations, alone or in combination, are consistent with the acceleration of the spontaneous rate of prolyl isomerization (Fig. 10.4). 

The design of selective and potent inhibitors of PPIases is of interest and numerous molecules have been designed or selected from chemical libraries with a view to curing these major diseases. The study of Pinl, which is clearly distinct from other members of the PPIase family on the basis of structure, binding site, catalytic mechanism, and biological implications, has opened up new perspectives in the biological chemistry of PPIases. The recent discoveries of the secondary amide peptide bond cis-trans isomerase (APIase) DnaK [209] and of a novel class of FK506 and cyclosporine-sensitive PPIase [210] are also major advances in this field. 

Beyond protein folding, the discovery of peptidyl prolyl isomerases (PPIases) and related proteins has opened the way to novel concepts in biology the notion of chaperone-assisted receptor binding is an emerging field of research which sheds light on receptor function and protein-protein interactions. The recent discovery of a secondary amide peptide bond cis-trans isomerase (APIase) heralds new advances in this field. 

Thus, by 1989 it was known that the cytosolic target of each of the three immunosuppressive drugs was a peptidylprolyl isomerase. The mechanism of action of the drugs was at that time unknown, and an attractive hypothesis was that inhibition of PPIase activity was critical... 

There is no common nomenclature for prolyl isomerases. The systematic name peptidylproline cis, trans-isomerase (E.C. 5.2.1.8) is shortened to prolyl isomerase, proline isomerase, PPI, or PPIase. Sometimes the expression rotamase is used. 

Conformational restriction played an important role in the discovery that water induces the bioactive conformation of CsA. Cyclosporin A (Sandimmune , CsA, (23.37), Fig. 23.7), is a major drug for preventing rejection of transplanted human organs and has been the subject of many synthetic, conformational and mechanism of action studies. To produce immunosuppression, CsA first binds to cyclophilin A (CyP A), a peptidyl prolyl cis-trans isomerase (PPIase), to form the CsA-CyP complex, which then binds to and inhibits calcineuiin (CaN), a calmodulin-dependent serine/threonine protein phosphatase, thereby inhibiting interleukin-2 (IL-2) synthesis. ... 

The essential lipoprotein PrsA, which localizes to the outer surface of the cytoplasmic membrane (Figure 7.1), can also be used to enhance secretion of particular proteins [65]. PrsA belongs to the parvulin subfamily of peptidyl-prolyl cis/trans isomerases (PPIases) [66]. The PPIase domain of PrsA exhibits PPIase activity and a possible chaperone activity in vivo at the membrane-cell wall interface [65]. Overexpression of PrsA was shown to enhance the secretion of several extracellular proteins, including a-amylases [57,65]. Furthermore, PrsA overproduction in B. subtilis resulted in 1.5-fold increased secretion and activity of the pharmacologically relevant human interferon-fi (hlNF-fi) with the AmyE propeptide [67]. 

---